Insider Trading activities at Biomarin Pharmaceutical Inc (BMRN) , Part 10

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1048477.

Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.


28 insiders reported insider trading activities at Biomarin Pharmaceutical Inc (BMRN):
Insider trading activities of Slamon Dennis
Insider trading activities of Aselage Steve
Insider trading activities of Swiedler Stuart J
Insider trading activities of Cooper Jeffrey H
Insider trading activities of Heron Elaine J
Insider trading activities of Starr Christopher M
Insider trading activities of Spiegelman Daniel K
Insider trading activities of Bienaime Jean Jacques
Insider trading activities of Ajer Jeffrey Robert
Insider trading activities of Lewis Alan
Insider trading activities of Davis George Eric
Insider trading activities of Mueller Brian
Insider trading activities of Lapalme Pierre
Insider trading activities of Klein Joseph Iii
Insider trading activities of Hubbard Cristin
Insider trading activities of Guyer Charles Greg
Insider trading activities of Dere Willard H
Insider trading activities of Lawlis V Bryan
Insider trading activities of Sager Erich
Insider trading activities of Kakkis Emil D
Insider trading activities of Grey Michael G
Insider trading activities of Burkhart Erin
Insider trading activities of Fuchs Henry J
Insider trading activities of Alles Mark J
Insider trading activities of Meier Richard A
Insider trading activities of Baffi Robert
Insider trading activities of Wood Mark
Insider trading activities of Pyott David E I

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Biomarin Pharmaceutical Inc (BMRN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 11,732 $809,525 0 $0
2024 0 $0 255,921 $21,765,611 199,347 $12,744,795
2023 0 $0 291,124 $29,165,285 298,974 $20,261,651
2022 3,625 $314,468 311,275 $27,255,098 253,242 $11,640,873
2021 0 $0 191,799 $15,370,940 178,931 $4,916,104
2020 12,800 $1,005,145 360,561 $39,226,570 301,650 $13,887,132
2019 0 $0 186,014 $16,384,008 131,953 $2,232,548
2018 0 $0 443,177 $39,824,783 396,390 $13,170,758
2017 0 $0 308,037 $28,193,855 265,930 $7,893,265
2016 0 $0 1,279,525 $111,508,495 1,208,448 $28,339,513
2015 0 $0 411,289 $48,410,265 295,446 $6,663,831
2014 0 $0 340,526 $26,836,672 306,781 $7,721,726
2013 0 $0 742,342 $47,391,614 730,412 $15,099,577
2012 0 $0 1,247,954 $51,415,184 1,198,637 $17,833,395
2011 0 $0 332,106 $9,638,946 335,054 $4,369,131
2010 800 $16,062 564,962 $13,310,700 545,102 $7,510,310
2009 26,500 $306,434 74,572 $1,277,220 83,753 $455,350
2008 16,752 $218,171 1,172,420 $39,560,526 973,113 $8,505,589
2007 17,587 $107,335 576,356 $12,583,816 477,563 $3,277,058
2006 35,493 $362,571 184,500 $2,780,052 284,500 $1,766,260
2005 12,000 $103,551 81,142 $826,127 0 $0


Table 3. Detailed insider trading at Biomarin Pharmaceutical Inc (BMRN) , Part 10
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-12-04 Davis George Eric (VP, General Counsel) Sale 7,000 16.30 114,079
2008-12-03 Lapalme Pierre (Director) Buy 2,400 15.29 36,703
2008-12-01 Kakkis Emil D (CHIEF MEDICAL OFFICER) Sale 17,000 15.87 269,790
2008-12-01 Kakkis Emil D (CHIEF MEDICAL OFFICER) Option Ex 17,000 6.13 104,210
2008-11-28 Wood Mark (VP, Human Resources) Sale 177 16.50 2,920
2008-11-28 Wood Mark (VP, Human Resources) Option Ex 177 6.13 1,085
2008-11-25 Kakkis Emil D (Chief Medical Officer) Sale 75,000 15.98 1,198,725
2008-11-03 Kakkis Emil D (Chief Medical Officer) Option Ex 33,000 12.12 400,026
2008-10-31 Davis George Eric (VP, General Counsel) Buy 186 13.35 2,483
2008-10-31 Kakkis Emil D (Chief Medical Officer) Buy 317 13.35 4,233
2008-10-21 Wood Mark (VP, Human Resources) Sale 177 20.22 3,578
2008-10-21 Wood Mark (VP, Human Resources) Option Ex 177 6.13 1,085
2008-10-01 Kakkis Emil D (Chief Medical Officer) Sale 18,000 26.27 472,878
2008-10-01 Kakkis Emil D (Chief Medical Officer) Option Ex 18,000 6.13 110,340
2008-09-22 Wood Mark (VP, Human Resources) Sale 2,468 28.33 69,915
2008-09-22 Wood Mark (VP, Human Resources) Option Ex 2,468 13.35 32,942
2008-09-02 Baffi Robert (SVP, Technical Operations) Sale 11,528 31.31 360,964
2008-09-02 Baffi Robert (SVP, Technical Operations) Option Ex 11,528 22.00 253,616
2008-09-02 Kakkis Emil D (Chief Medical Officer) Sale 18,000 30.19 543,384
2008-09-02 Kakkis Emil D (Chief Medical Officer) Option Ex 6,000 6.13 36,780
2008-08-21 Wood Mark (VP, Human Resources) Sale 2,469 26.10 64,435
2008-08-21 Wood Mark (VP, Human Resources) Option Ex 2,469 13.35 32,956
2008-08-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 600 6.46 3,876
2008-08-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 650 6.46 4,199
2008-08-07 Bienaime Jean Jacques (Chief Executive Office) Option Ex 1,000 6.46 6,460
2008-08-06 Bienaime Jean Jacques (Chief Executive Office) Option Ex 1,200 6.46 7,752
2008-08-01 Kakkis Emil D (Chief Medical Officer) Sale 18,000 32.46 584,352
2008-07-30 Baffi Robert (SVP, Technical Operations) Sale 19,528 31.75 620,160
2008-07-30 Baffi Robert (SVP, Technical Operations) Option Ex 19,528 22.00 429,616
2008-07-21 Wood Mark (VP, Human Resources) Sale 2,468 30.25 74,657
2008-07-21 Wood Mark (VP, Human Resources) Option Ex 2,468 13.35 32,942
2008-07-15 Davis George Eric (VP, General Counsel) Sale 5,000 28.00 140,000
2008-07-15 Davis George Eric (VP, General Counsel) Option Ex 5,000 6.13 30,650
2008-07-08 Wood Mark (VP, Human Resources) Sale 350 28.20 9,868
2008-07-07 Kakkis Emil D (Chief Medical Officer) Sale 18,000 28.04 504,792
2008-07-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 15,000 28.34 425,175
2008-07-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 15,000 6.13 91,950
2008-06-30 Baffi Robert (SVP, Technical Operations) Sale 3,528 30.02 105,924
2008-06-30 Baffi Robert (SVP, Technical Operations) Option Ex 3,528 22.00 77,616
2008-06-23 Wood Mark (VP, Human Resources) Sale 2,292 32.61 74,735
2008-06-23 Wood Mark (VP, Human Resources) Option Ex 2,292 15.15 34,728
2008-06-16 Davis George Eric (VP, General Counsel) Option Ex 10,000 7.84 78,400
2008-06-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 39.00 117,000
2008-06-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 6.46 19,380
2008-06-04 Wood Mark (VP, Human Resources) Sale 1,323 37.66 49,825
2008-06-04 Wood Mark (VP, Human Resources) Option Ex 1,323 12.56 16,611
2008-06-02 Kakkis Emil D (Chief Medical Officer) Sale 18,000 37.63 677,286
2008-06-02 Kakkis Emil D (Chief Medical Officer) Option Ex 16,000 4.00 64,000
2008-05-30 Baffi Robert (SVP, Technical Operatons) Sale 11,528 38.57 443,395
2008-05-30 Baffi Robert (SVP, Technical Operations) Option Ex 11,528 22.00 253,616
2008-05-21 Wood Mark (VP, Human Resources) Sale 1,667 39.17 65,298
2008-05-21 Wood Mark (VP, Human Resources) Option Ex 1,667 11.81 19,692
2008-05-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 39.10 195,524
2008-05-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 6.46 32,300
2008-05-13 Davis George Eric (VP, General Counsel) Sale 10,000 39.15 391,520
2008-05-13 Davis George Eric (VP, General Counsel) Option Ex 10,000 11.74 117,400
2008-05-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 39.18 195,890
2008-05-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 6.46 32,300
2008-05-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 39.04 312,320
2008-05-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 6.46 51,680
2008-05-06 Aselage Steve (SVP, Global Commercial Dev.) Sale 16,200 37.75 611,550
2008-05-06 Aselage Steve (SVP, Global Commercial Dev.) Option Ex 12,205 9.45 115,337
2008-05-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 36.55 182,775
2008-05-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 6.46 32,300
2008-05-02 Aselage Steve (SVP, Global Commercial Dev.) Sale 3,800 37.75 143,450
2008-05-02 Aselage Steve (SVP, Global Commercial Dev.) Option Ex 2,900 7.16 20,764
2008-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,100 36.87 372,387
2008-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 6.46 64,600
2008-05-01 Kakkis Emil D (Chief Medical Officer) Sale 18,000 37.46 674,262
2008-05-01 Kakkis Emil D (Chief Medical Officer) Option Ex 18,000 4.00 72,000
2008-05-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,453 37.21 277,341
2008-05-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 6.46 32,300
2008-04-30 Davis George Eric (VP, General Counsel) Buy 1,810 10.37 18,769
2008-04-30 Davis George Eric (VP, General Counsel) Sale 5,000 36.51 181,626
2008-04-30 Davis George Eric (VP, General Counsel) Option Ex 5,000 7.84 39,200
2008-04-30 Cooper Jeffrey H (SVP, Chief Financial Officer) Buy 1,070 13.95 14,925
2008-04-30 Baffi Robert (SVP, Technical Operations) Buy 1,754 10.37 18,188
2008-04-30 Kakkis Emil D (Chief Medical Officer) Buy 1,640 10.37 17,006
2008-04-30 Aselage Steve (SVP, Global Commercial Dev.) Buy 1,526 10.37 15,824
2008-04-30 Bienaime Jean Jacques (Chief Executive Officer) Buy 2,049 10.37 21,248
2008-04-29 Kakkis Emil D (Chief Medical Officer) Option Ex 75,000 4.00 300,000
2008-04-21 Wood Mark (VP, Human Resources) Sale 2,990 33.99 101,618
2008-04-21 Wood Mark (VP, Human Resources) Option Ex 2,990 12.19 36,433
2008-04-02 Baffi Robert (SVP, Technical Operations) Sale 38,762 36.99 1,432,894
2008-04-02 Baffi Robert (SVP, Technical Operations) Option Ex 38,762 6.95 269,202
2008-04-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 35.95 449,400
2008-04-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 6.13 76,625
2008-04-01 Kakkis Emil D (Chief Medical Officer) Sale 18,000 35.84 645,189
2008-04-01 Kakkis Emil D (Chief Medical Officer) Option Ex 18,000 4.00 72,000
2008-04-01 Aselage Steve (SVP, Global Commercial Dev) Sale 805 35.98 28,963
2008-04-01 Aselage Steve (SVP, Global Commercial Dev) Option Ex 805 7.16 5,763
2008-03-25 Baffi Robert (SVP, Technical Operations) Sale 34,998 35.87 1,256,096
2008-03-25 Baffi Robert (SVP, Technical Operations) Option Ex 34,998 9.93 347,530
2008-03-24 Wood Mark (VP, Human Resources) Sale 2,989 35.05 104,758
2008-03-24 Wood Mark (VP, Human Resources) Option Ex 2,989 12.19 36,420
2008-03-18 Baffi Robert (SVP, Technical Operations) Sale 46,240 32.44 1,498,432
2008-03-18 Baffi Robert (SVP, Technical Operations) Option Ex 46,240 12.10 559,504
2008-03-14 Baffi Robert (SVP, Technical Operations) Sale 76,486 33.11 2,556,386
2008-03-14 Baffi Robert (SVP, Technical Operations) Option Ex 76,486 9.50 726,616
2008-03-06 Kakkis Emil D (Chief Medical Officer) Sale 18,000 38.15 686,610
2008-03-06 Kakkis Emil D (Chief Medical Officer) Option Ex 18,000 4.00 72,000
2008-03-06 Heron Elaine J (Director) Sale 30,000 37.95 1,139,683
2008-03-06 Heron Elaine J (Director) Option Ex 60,000 7.75 465,000
2008-03-05 Grey Michael G (Director) Sale 25,000 38.30 955,555
2008-03-05 Grey Michael G (Director) Option Ex 30,000 10.33 309,900
2008-03-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 38.00 152,000
2008-03-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 6.46 25,840
2008-03-03 Davis George Eric (VP, General Counsel) Sale 20,000 38.00 760,000
2008-03-03 Davis George Eric (VP, General Counsel) Option Ex 20,000 6.99 139,700
2008-03-03 Heron Elaine J (Director) Sale 20,000 38.47 769,400
2008-03-03 Aselage Steve (SVP, Global Commercial Dev) Sale 40,000 38.00 1,520,000
2008-03-03 Aselage Steve (SVP, Global Commercial Dev) Option Ex 65,000 9.45 614,250
2008-03-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 38.13 76,262
2008-03-03 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 6.46 12,920
2008-03-03 Klein Joseph Iii (Director) Sale 10,000 38.05 380,550
2008-02-29 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 55,625 37.80 2,096,636
2008-02-29 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 55,625 7.78 432,540
2008-02-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 21,142 38.11 805,700
2008-02-29 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 18,000 6.46 116,280
2008-02-29 Klein Joseph Iii (Director) Option Ex 30,000 14.21 426,300
2008-02-29 Lapalme Pierre (Director) Sale 15,000 38.02 569,531
2008-02-29 Lapalme Pierre (Director) Option Ex 15,000 5.92 88,800
2008-01-22 Wood Mark (VP, Human Resources) Sale 2,990 36.31 108,572
2008-01-22 Wood Mark (VP, Human Resources) Option Ex 2,990 12.19 36,433
2008-01-02 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 36.16 452,037
2008-01-02 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 6.13 76,625
2008-01-02 Aselage Steve (SVP, Global Commercial Dev) Sale 5,000 36.09 180,475
2008-01-02 Aselage Steve (SVP, Global Commercial Dev) Option Ex 5,000 7.16 35,800
2008-01-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 36.09 541,410
2008-01-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 6.46 96,900
2007-12-21 Wood Mark (VP, Human Resources) Sale 6,114 36.08 220,562
2007-12-21 Wood Mark (VP, Human Resources) Option Ex 6,114 12.19 74,499
2007-12-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 35.53 532,980
2007-12-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 6.46 96,900
2007-11-21 Wood Mark (VP, Human Resources) Sale 2,365 25.82 61,052
2007-11-21 Wood Mark (VP, Human Resources) Option Ex 2,365 11.16 26,383
2007-10-31 Kakkis Emil D (Chief Medical Officer) Buy 2,038 6.92 14,100
2007-10-31 Aselage Steve (SVP, Global Commercial Dev) Buy 2,139 6.92 14,799
2007-10-31 Bienaime Jean Jacques (Chief Executive Officer) Buy 518 6.92 3,584
2007-10-24 Wood Mark (VP, Human Resources) Sale 833 26.00 21,658
2007-10-24 Wood Mark (VP, Human Resources) Option Ex 833 17.54 14,610
2007-10-22 Wood Mark (VP, Human Resources) Sale 1,532 25.30 38,761
2007-10-22 Wood Mark (VP, Human Resources) Option Ex 1,532 9.56 14,645
2007-10-11 Davis George Eric (VP, General Counsel) Sale 5,000 27.34 136,700
2007-10-11 Davis George Eric (VP, General Counsel) Option Ex 5,000 8.05 40,250
2007-10-08 Wood Mark (VP, Human Resources) Sale 8,333 26.00 216,658
2007-10-08 Wood Mark (VP, Human Resources) Option Ex 8,333 17.54 146,160
2007-10-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 12,380 26.00 321,880
2007-10-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 12,380 8.10 100,278
2007-10-01 Davis George Eric (VP, General Counsel) Sale 5,000 25.10 125,500

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.